are glp 1 drugs safe for weight loss GLP-1 from the Gray Market Infographic: Understanding Weight Loss Medications
Description
Glucagon-like Peptide-1 Receptor-Based Therapeutics for Metabolic Liver Disease
The market for GLP-1 RAs is dominated by Novo Nordisk, Eli Lilly, AstraZeneca, Bristol Myers Squibb and GSK
Semaglutide is a medication used in weight loss treatment
What are the most common side effects with GLP-1s
That means we have limited data on how these drugs work in the real world for diverse patients, and we risk reinforcing disparities if access remains limited
